Literature DB >> 18780360

In vitro biodegradation of designed tubular scaffolds of electrospun protein/polyglyconate blend fibers.

Xing Zhang1, Vinoy Thomas, Yogesh K Vohra.   

Abstract

Electrospun polyglyconate (Maxon) and its blends with proteins such as gelatin and elastin, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering. In vitro biodegradation of the electrospun tubular protein/Maxon scaffolds in phosphate buffered saline (pH = 7.3) was studied for the first time. The biodegradation is manifested by uptake of the PBS medium by the hydrophilic proteins and also by the mass loss due to the removal of degraded fragments and uncrosslinked proteins from the matrices. The effect of degradation on the structure-property relations was evaluated by IR, XRD, and DSC analyses of the aged scaffolds. The degradation of amorphous phase of Maxon in the early stages of aging has resulted in an increase in the crystallinity of the polymer. SEM analysis indicated a significant change in nanofiber morphology and fiber-breaking. The mass loss and fiber breaking have negatively impacted the mechanical properties and the effect was maximum at 15-20 days of aging. The scaffold containing low molecular weight buffer soluble elastin revealed relatively better degradation properties compared to that containing high molecular weight buffer insoluble elastin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18780360     DOI: 10.1002/jbm.b.31196

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  12 in total

Review 1.  Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration.

Authors:  Robert L Mauck; Brendon M Baker; Nandan L Nerurkar; Jason A Burdick; Wan-Ju Li; Rocky S Tuan; Dawn M Elliott
Journal:  Tissue Eng Part B Rev       Date:  2009-06       Impact factor: 6.389

Review 2.  Emerging techniques in stratified designs and continuous gradients for tissue engineering of interfaces.

Authors:  Nathan H Dormer; Cory J Berkland; Michael S Detamore
Journal:  Ann Biomed Eng       Date:  2010-04-22       Impact factor: 3.934

3.  Fibro-porous poliglecaprone/polycaprolactone conduits: synergistic effect of composition and in vitro degradation on mechanical properties.

Authors:  Harsh N Patel; Roman Garcia; Carrie Schindler; Derrick Dean; Steven M Pogwizd; Raj Singh; Yogesh K Vohra; Vinoy Thomas
Journal:  Polym Int       Date:  2015-04       Impact factor: 2.990

4.  Two ply tubular scaffolds comprised of proteins/poliglecaprone/polycaprolactone fibers.

Authors:  Xing Zhang; Vinoy Thomas; Yogesh K Vohra
Journal:  J Mater Sci Mater Med       Date:  2009-11-10       Impact factor: 3.896

5.  Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges.

Authors:  Vivek A Kumar; Luke P Brewster; Jeffrey M Caves; Elliot L Chaikof
Journal:  Cardiovasc Eng Technol       Date:  2011-09-01       Impact factor: 2.495

6.  A tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation.

Authors:  Qingyi He; Xiaohui Wang; Xing Zhang; Huifang Han; Baosan Han; Jianzhong Xu; Kanglai Tang; Zhiren Fu; Hao Yin
Journal:  Int J Nanomedicine       Date:  2013-03-19

7.  Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery.

Authors:  Qian Zhan; Baiyong Shen; Xiaxing Deng; Hao Chen; Jiabin Jin; Xing Zhang; Chenghong Peng; Hongwei Li
Journal:  Int J Nanomedicine       Date:  2013-07-11

8.  The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders.

Authors:  Cai Yong; Zhengxin Wang; Xing Zhang; Xiaomin Shi; Zhijia Ni; Hong Fu; Guoshan Ding; Zhiren Fu; Hao Yin
Journal:  Int J Nanomedicine       Date:  2014-02-17

9.  The therapeutic role of monocyte chemoattractant protein-1 in a renal tissue engineering strategy for diabetic patients.

Authors:  Hao Yin; Ming Gao; Lara Leoni; Huifang Han; Xing Zhang; Zhiren Fu
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  A synergistic therapeutic scheme for hyperglycemia and nephrotic disorders in diabetes.

Authors:  Qingyi He; Xing Zhang; Baosan Han; Jianzhong Xu; Kanglai Tang; Zhiren Fu; Hao Yin
Journal:  Theranostics       Date:  2014-03-05       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.